Late toxicity after postprostatectomy salvage radiation therapy.

[1]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[2]  Michel Bolla,et al.  Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  Richard K Valicenti,et al.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  K. Haustermans.  EORTC radiation oncology group , 2007 .

[5]  E. Messing,et al.  Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. , 2006, JAMA.

[6]  M. Heckman,et al.  Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. , 2006, The Journal of urology.

[7]  M. Zelefsky.  Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911) , 2006 .

[8]  D. Kuban,et al.  Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[9]  M. Piérart,et al.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) , 2005, The Lancet.

[10]  F. Montorsi,et al.  Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. , 2004, International Journal of Radiation Oncology, Biology, Physics.

[11]  M. Cooperberg,et al.  The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. , 2004, The Journal of urology.

[12]  S. Schild,et al.  Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. , 2003, The Journal of urology.

[13]  P. Walsh.  (In)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. , 2003, The Journal of urology.

[14]  B. Norlén,et al.  Postoperative Radiotherapy after Prostatectomy A Review , 2003, Scandinavian journal of urology and nephrology.

[15]  M. Piérart,et al.  Acute and late toxicity of post-operative external irradiation in pT3N0 prostate cancer patients treated within EORTC trial 22911 , 2002 .

[16]  T. P. Cooper,et al.  2001 American Urological Association Gallup Survey: changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction. , 2002, The Journal of urology.

[17]  R. Stephenson.  Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. , 2002, The Urologic clinics of North America.

[18]  D. Kuban,et al.  Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. , 2001, International journal of radiation oncology, biology, physics.

[19]  J W Moul,et al.  Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. , 2000, The Journal of urology.

[20]  A W Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[21]  M. Zelefsky,et al.  Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. , 1997, International journal of radiation oncology, biology, physics.

[22]  J. Forman,et al.  Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation. , 1996, Urology.

[23]  S. Groshen,et al.  Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. , 1996, The Journal of urology.

[24]  T. Stamey,et al.  Incontinence and vesical neck strictures following radical retropubic prostatectomy. , 1995, Urology.

[25]  G. Montana,et al.  The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. , 1995, International journal of radiation oncology, biology, physics.

[26]  H. Zincke,et al.  Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancer. , 1995, Oncology.

[27]  J. Smith,et al.  Postoperative radiation therapy for pathologic stage C prostate cancer. , 1987, International journal of radiation oncology, biology, physics.

[28]  M B Brown,et al.  Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. , 1986, The Journal of urology.

[29]  M. Pilepich,et al.  Postoperative irradiation in carcinoma of the prostate. , 1984, International journal of radiation oncology, biology, physics.

[30]  J. Cheville,et al.  Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. , 2000, The Journal of urology.

[31]  F. Richard,et al.  Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. , 1998, The Journal of urology.

[32]  A. Zietman,et al.  Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[33]  H. Fukuda,et al.  European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Blood 2008; 112(5):1600-9 , 2022 .

[34]  N. Dubrawsky.  Cancer statistics , 2022 .